Orion Portfolio Solutions’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.78M Buy
27,908
+1,836
+7% +$107K 0.02% 772
2024
Q4
$1.25M Sell
26,072
-5,041
-16% -$258K 0.01% 928
2024
Q3
$1.78M Sell
31,113
-1,760
-5% -$101K 0.02% 751
2024
Q2
$1.72M Sell
32,873
-2,661
-7% -$117K 0.02% 718
2024
Q1
$1.45M Buy
35,534
+5,809
+20% +$218K 0.02% 809
2023
Q4
$1.06M Sell
29,725
-5,635
-16% -$212K 0.01% 920
2023
Q3
$1.35M Sell
35,360
-3,162
-8% -$130K 0.02% 789
2023
Q2
$1.39M Sell
38,522
-2,657
-6% -$90.7K 0.01% 810
2023
Q1
$1.57M Buy
+41,179
New +$1.93M 0.02% 694
2020
Q1
Sell
-301
Closed -$5K 2059
2019
Q4
$5K Buy
+301
New +$5.21K ﹤0.01% 1253

Other funds holding HALO

Orion Portfolio Solutions's HALO Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Halozyme (HALO) stake by 7% in Q1 2025, buying an estimated $107K and bringing the position to 27,908 shares worth $1.78M. The position accounts for 0.02% of the portfolio, ranked #772.

Orion Portfolio Solutions first reported a position in HALO in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.78M in Q3 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Orion Portfolio Solutions held 27,908 shares of Halozyme worth $1.78M as of Q1 2025.
  • Orion Portfolio Solutions bought 1,836 Halozyme shares in Q1 2025, an estimated $107K.
  • Halozyme made up 0.02% of Orion Portfolio Solutions's portfolio in Q1 2025, its #772 holding.
  • Orion Portfolio Solutions first reported a position in Halozyme in Q4 2019 and has held it in 10 quarters since.
  • Orion Portfolio Solutions's Halozyme position peaked at $1.78M in Q3 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.